
Annual report 2025
added 02-27-2026
Teleflex Incorporated Cash Flow 2011-2026 | TFX
Annual Cash Flow Teleflex Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Depreciation & Amortization |
178 M | 162 M | 148 M | 231 M | 237 M | 227 M | 218 M | 215 M | 160 M | 128 M | 125 M | 127 M | 108 M | 94.9 M | 96.5 M |
Accounts Payables |
130 M | 97.9 M | 132 M | 127 M | 118 M | 103 M | 103 M | 107 M | 92 M | 69.4 M | 66.3 M | 64.1 M | 72 M | 75.2 M | 67.1 M |
Accounts Receivables |
346 M | 227 M | 443 M | 409 M | 384 M | 395 M | 419 M | 366 M | 346 M | 272 M | 262 M | 274 M | 295 M | 298 M | 286 M |
Total Inventories |
404 M | 307 M | 626 M | 579 M | 478 M | 513 M | 477 M | 428 M | 396 M | 316 M | 330 M | 336 M | 334 M | 323 M | 299 M |
All numbers in USD currency
Quarterly Cash Flow Teleflex Incorporated
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Depreciation & Amortization |
77.9 M | 65.7 M | 67.3 M | 68.6 M | 68.1 M | 66 M | - | - | 18.3 M | - | 49.1 M | - | 17.3 M | - | 53.8 M | - | 17.5 M | - | 51.3 M | 34.5 M | 16.8 M | - | 47.3 M | 32 M | 15.6 M | - | 44.5 M | 29.5 M | 14.8 M | - | 42.4 M | 28.1 M | 14.2 M | - | 40.3 M | 26.6 M | 12.6 M | - | 31.3 M | 30.8 M | 29.8 M | - | 32.4 M | 32.4 M | 31.4 M | - | 27.1 M | 25.6 M | 26.3 M | - | 23.7 M | 22.8 M | 22.7 M | - | 24.2 M | 24.4 M | 10.3 M |
Accounts Payables |
166 M | 158 M | 143 M | 119 M | 113 M | 116 M | 131 M | 142 M | 136 M | 127 M | 122 M | - | 117 M | 118 M | 104 M | 107 M | 101 M | 103 M | 103 M | 103 M | 103 M | 103 M | 103 M | 103 M | 103 M | 107 M | 107 M | 107 M | 107 M | 92 M | 92 M | 92 M | 92 M | 69.4 M | 69.4 M | 69.4 M | 69.4 M | 66.3 M | 66.3 M | 66.3 M | 66.3 M | 64.1 M | 64.1 M | 64.1 M | 64.1 M | 72 M | 72 M | 72 M | 72 M | 75.2 M | 75.2 M | 75.2 M | 75.2 M | 67.1 M | 67.1 M | 67.1 M | 67.1 M |
Accounts Receivables |
593 M | 514 M | 465 M | 470 M | 449 M | 449 M | 425 M | 429 M | 410 M | 409 M | 391 M | - | 407 M | 384 M | 400 M | 414 M | 401 M | 395 M | 395 M | 395 M | 395 M | 419 M | 419 M | 419 M | 419 M | 366 M | 366 M | 366 M | 366 M | 346 M | 346 M | 346 M | 346 M | 272 M | 272 M | 272 M | 272 M | 262 M | 262 M | 262 M | 262 M | 274 M | 274 M | 274 M | 274 M | 295 M | 295 M | 295 M | 295 M | 298 M | 298 M | 298 M | 298 M | 286 M | 286 M | 286 M | 286 M |
Total Inventories |
802 M | 694 M | 644 M | 640 M | 637 M | 628 M | 625 M | 632 M | 614 M | 579 M | 530 M | - | 491 M | 478 M | 484 M | 490 M | 512 M | 513 M | 513 M | 513 M | 513 M | 477 M | 477 M | 477 M | 477 M | 428 M | 428 M | 428 M | 428 M | 396 M | 396 M | 396 M | 396 M | 316 M | 316 M | 316 M | 316 M | 330 M | 330 M | 330 M | 330 M | 336 M | 336 M | 336 M | 336 M | 334 M | 334 M | 334 M | 334 M | 323 M | 323 M | 323 M | 323 M | 299 M | 299 M | 299 M | 299 M |
All numbers in USD currency
Cash Flow Statement is one of the three key financial reports of the company Teleflex Incorporated, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.
Main Sections of the Cash Flow Statement- Operating Activities
This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash. - Investing Activities
Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign. - Financing Activities
Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.
The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.
Cash flow statements of other stocks in the Medical instruments sector
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
AtriCure
ATRC
|
$ 31.07 | -1.26 % | $ 1.48 B | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | ||
|
The Cooper Companies
COO
|
$ 81.93 | -1.73 % | $ 16.3 B | ||
|
Alcon
ALC
|
$ 84.0 | 1.13 % | $ 40.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.9 | 9.0 % | $ 26.4 M | ||
|
Baxter International
BAX
|
$ 19.1 | 0.45 % | $ 9.8 B | ||
|
Glaukos Corporation
GKOS
|
$ 115.62 | -1.86 % | $ 5.6 B | ||
|
Haemonetics Corporation
HAE
|
$ 64.55 | -1.59 % | $ 3.25 B | ||
|
InfuSystem Holdings
INFU
|
$ 9.57 | 4.25 % | $ 198 M | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | ||
|
iRhythm Technologies
IRTC
|
$ 127.87 | 1.61 % | $ 4.09 B | ||
|
Repro Med Systems
KRMD
|
$ 4.88 | 2.2 % | $ 223 M | ||
|
Harvard Bioscience
HBIO
|
$ 0.58 | 2.14 % | $ 24.6 M | ||
|
LeMaitre Vascular
LMAT
|
$ 106.91 | -0.87 % | $ 2.42 B | ||
|
Becton, Dickinson and Company
BDX
|
$ 171.22 | -1.8 % | $ 49.3 B | ||
|
Masimo Corporation
MASI
|
$ 175.43 | 0.04 % | $ 9.35 B | ||
|
Microbot Medical
MBOT
|
$ 2.47 | 3.28 % | $ 25.2 M | ||
|
AngioDynamics
ANGO
|
$ 10.98 | -0.54 % | $ 449 M | ||
|
BioLife Solutions
BLFS
|
$ 20.59 | 2.06 % | $ 949 M | ||
|
Nephros
NEPH
|
$ 3.92 | 1.29 % | $ 40.7 M | ||
|
electroCore
ECOR
|
$ 7.9 | 3.81 % | $ 43.6 K | ||
|
Envista Holdings Corporation
NVST
|
$ 28.51 | -0.52 % | $ 4.79 B | ||
|
Retractable Technologies
RVP
|
$ 0.68 | -3.05 % | $ 20.4 M | ||
|
ICU Medical
ICUI
|
$ 142.18 | -0.34 % | $ 3.5 B | ||
|
Intuitive Surgical
ISRG
|
$ 501.88 | 0.9 % | $ 179 B | ||
|
Pulse Biosciences
PLSE
|
$ 18.29 | 1.89 % | $ 1.23 B | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | ||
|
Merit Medical Systems
MMSI
|
$ 74.53 | -0.43 % | $ 4.41 B | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | ||
|
Repligen Corporation
RGEN
|
$ 126.05 | 2.43 % | $ 7.02 M | ||
|
OraSure Technologies
OSUR
|
$ 3.0 | 0.67 % | $ 223 M | ||
|
ResMed
RMD
|
$ 258.94 | 0.22 % | $ 37.8 B | ||
|
Pro-Dex
PDEX
|
$ 48.51 | 2.1 % | $ 159 M | ||
|
STAAR Surgical Company
STAA
|
$ 19.17 | 1.32 % | $ 950 M | ||
|
STERIS plc
STE
|
$ 244.67 | 0.62 % | $ 24.1 B | ||
|
Stereotaxis
STXS
|
$ 2.22 | 3.74 % | $ 179 M | ||
|
Utah Medical Products
UTMD
|
$ 67.17 | 0.99 % | $ 244 M | ||
|
West Pharmaceutical Services
WST
|
$ 250.46 | -0.3 % | $ 18.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
$ 13.47 | 1.24 % | $ 2.69 B | ||
|
Milestone Scientific
MLSS
|
$ 0.29 | 2.33 % | $ 23.1 M |